[HTML][HTML] Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid …
B Dholaria, M Labopin, J Sanz, A Ruggeri… - Journal of hematology & …, 2021 - Springer
Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz… - … of hematology & …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz, A Ruggeri… - … of Hematology & …, 2021 - inria.hal.science
Background: Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
B Dholaria, M Labopin, J Sanz, A Ruggeri… - Journal of hematology …, 2021 - orbi.uliege.be
BACKGROUND: Allogeneic hematopoietic cell transplantation (allo-HCT) using a
mismatched unrelated donor (MMUD) and cord blood transplantation (CBT) are valid …
mismatched unrelated donor (MMUD) and cord blood transplantation (CBT) are valid …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz… - … of Hematology & …, 2021 - hal.sorbonne-universite.fr
Background: Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
[PDF][PDF] Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid …
B Dholaria, M Labopin, J Sanz, A Ruggeri… - 2021 - pure.eur.nl
Background: Allogeneic hematopoietic cell transplantation (allo‑HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz… - … of Hematology & …, 2021 - search.proquest.com
Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz, A Ruggeri… - Journal of Hematology …, 2021 - hal.science
Background: Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz, A Ruggeri… - … OF HEMATOLOGY & …, 2021 - iris.unisr.it
Background: Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
B Dholaria, M Labopin, J Sanz, A Ruggeri… - … of Hematology & …, 2021 - europepmc.org
Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …